SION

Sionna Therapeutics, Inc.

There isn't enough reported data to score SION yet.

SION Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

SION's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

SION PE Valuation

SION has no meaningful PE right now: it lost money over the past year.

SION Forward outlook

MetricOutlook
--
Losses shrinking
--
--
Limited
Low

Analysts expect SION's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.

SION Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $3.43 on Nov 12.

There is not enough scenario data to assess SION's risk to reward.

SION Earnings Per Share

Q3 2024: $-1.31Q4 2024: $-1.40Q2 2026: $-2.18Q3 2026: $-2.44
Q3 2024: $-1.31Q4 2024: $-1.40Q2 2026: $-2.18Q3 2026: $-2.44

SION Quarterly Revenue

Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

SION Free Cash Flow

Q4 2023: −$8MQ1 2024: −$13MQ2 2024: −$10MQ3 2024: −$18MQ4 2024: −$12MQ1 2025: −$16MQ2 2025: −$18MQ3 2025: −$15MQ4 2025: −$17MQ1 2026: −$22MQ2 2026: −$22MQ3 2026: −$19M
Q4 2023: −$8MQ1 2024: −$13MQ2 2024: −$10MQ3 2024: −$18MQ4 2024: −$12MQ1 2025: −$16MQ2 2025: −$18MQ3 2025: −$15MQ4 2025: −$17MQ1 2026: −$22MQ2 2026: −$22MQ3 2026: −$19M
QuarterFree cash flowYoY
Q3 2026-$18.7M-$3.4M
Q2 2026-$22.2M-$4.1M
Q1 2026-$21.8M-$5.5M
Q4 2025-$16.8M-$5M
Q3 2025-$15.3M+$2.4M
Q2 2025-$18.2M-$8M
Q1 2025-$16.4M-$3.2M
Q4 2024-$11.8M-$4.2M

SION has burned cash in almost every quarter: −$80M over the past year, against −$62M the year before.

SION Total Shares

Q4 2023: 44MQ1 2024: 44MQ2 2024: 44MQ3 2024: 44MQ4 2024: 44MQ1 2025: 27MQ2 2025: 44MQ3 2025: 44MQ4 2025: 40MQ1 2026: 45MQ2 2026: 45MQ3 2026: 45M
Q4 2023: 44MQ1 2024: 44MQ2 2024: 44MQ3 2024: 44MQ4 2024: 44MQ1 2025: 27MQ2 2025: 44MQ3 2025: 44MQ4 2025: 40MQ1 2026: 45MQ2 2026: 45MQ3 2026: 45M
PeriodChange %Net change
Quarterly+0.1%+60K shares
1 year+2.2%+954K shares

SION has 45M diluted shares, up 2.2% from a year ago.

SION Net Leverage

SION's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

SION Weekly Momentum

MetricValueStatus
RSI28.5Oversold
Stochastic1.8Oversold

SION's weekly RSI is 29 (oversold) and its Stochastic is 2 (oversold).

SION PE vs Healthcare Sector

SION has no meaningful PE right now: it lost money over the past year.

SION Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.1417% below
20 week MA$17.781% below
50 week MA$30.789% below

SION is in a downtrend: it's below all three of its weekly moving averages, and 89% below its 50-week average.

SION Yearly ROI

YearStart priceEnd priceROI
2025$25.0$43.7+75%
2026 YTD$43.7$3.43-92%

SION has finished every year since 2025 higher, and it's down 92% so far in 2026.

Give your agent the market.

Get API key